DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
Heptinstall S, Espinosa DI, Manolopoulos P, Glenn JR, White AE, Johnson A, Dovlatova N, Fox SC, May JA, Hermann D, Magnusson O, Stefansson K, Hartman D, Gurney M.
Heptinstall S, et al. Among authors: fox sc.
Platelets. 2008 Dec;19(8):605-13. doi: 10.1080/09537100802351073.
Platelets. 2008.
PMID: 19012178
Free article.